Understanding how genetic variants in non-coding regions affect disease risk is a major challenge. Standard Hi-C often lacks the resolution to link these variants to their target genes, while ATAC-seq identifies the variants but not their targets. A 2022 study published in Molecular Cell sought to resolve this using HiCAR.
The researchers applied HiCAR to K562 human leukemia cells and primary human muscle stem cells. They aimed to validate the method's ability to capture both open chromatin features and high-resolution chromatin loops from low-input material.
The HiCAR data (Figure 3A) demonstrated a striking concordance with separate high-depth Hi-C and ATAC-seq datasets. Crucially, HiCAR successfully identified high-resolution enhancer-promoter loops that were specifically anchored at open chromatin regions. These "anchored" loops provided a much cleaner regulatory map than standard Hi-C, which often contains structural noise.

This study established HiCAR as a robust, sensitive, and efficient method for analyzing open-chromatin-associated genome organization. It confirmed that HiCAR can serve as a powerful "all-in-one" tool for dissecting the 3D regulatory genome. (Source: HiCAR is a robust and sensitive method to analyze open-chromatin-associated genome organization, Molecular Cell, 2022.)



Integrated Tracks